Medina Alex, Nilles Christelle, Martino Davide, Pelletier Catherine, Pringsheim Tamara
Department of Clinical Neurosciences, Cumming School of Medicine University of Calgary Calgary Alberta Canada.
Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada.
Mov Disord Clin Pract. 2022 Aug 24;9(7):860-868. doi: 10.1002/mdc3.13524. eCollection 2022 Oct.
A systematic review of epidemiological studies of primary dystonia from 1985 and 2010 found an overall prevalence of 16.43 per 100,000 (95% CI = 12.09-22.32).
We performed a systematic review of studies from 2010 and 2022 to determine if there are important differences in epidemiology between these time periods.
Nineteen studies were included. Incidence of cervical dystonia, blepharospasm, and oromandibular dystonia were each reported in one study; one study reported incidence for all adult onset idiopathic focal dystonias combined. Using data from 11 studies, we performed random effects meta-analyses of the prevalence of cervical dystonia (9.95 per 100,000; 95% CI = 3.51-28.17), blepharospasm (2.82 per 100,000; 95% CI = 1.12-7.12), laryngeal dystonia (0.40 per 100,000; 95% CI = 0.09-1.83), upper limb dystonia (1.27 per 100,000; 95% CI = 0.36-4.52), oromandibular dystonia (0.57 per 100,000; 95% CI = 0.15-2.15), and idiopathic or inherited isolated dystonia all subtypes combined (30.85 per 100,000; 95% CI = 5.06-187.74). All studies reported more cases of dystonia in females. There was no significant difference in prevalence by subgroup analysis based on time of study publication (1985-2010 vs. 2010-2022). Subgroup analysis of differences in prevalence by dystonia subtype by continent using all studies published (1985-2022) revealed significant regional differences in the prevalence of cervical and laryngeal dystonia.
The incidence and prevalence of idiopathic or inherited isolated dystonia in the last decade was not significantly different from earlier reports. Population-based studies across multiple geographic areas are needed to obtain a clearer understanding of the epidemiology of this condition.
一项对1985年至2010年原发性肌张力障碍流行病学研究的系统评价发现,总体患病率为每10万人16.43例(95%置信区间=12.09-22.32)。
我们对2010年至2022年的研究进行了系统评价,以确定这些时间段之间在流行病学方面是否存在重要差异。
纳入了19项研究。一项研究报告了颈部肌张力障碍、眼睑痉挛和口下颌肌张力障碍的发病率;一项研究报告了所有成人起病的特发性局灶性肌张力障碍合并症的发病率。利用11项研究的数据,我们对颈部肌张力障碍(每10万人9.95例;95%置信区间=3.51-28.17)、眼睑痉挛(每10万人2.82例;95%置信区间=1.12-7.12)、喉肌张力障碍(每10万人0.40例;95%置信区间=0.09-1.83)、上肢肌张力障碍(每10万人1.27例;95%置信区间=0.36-4.52)、口下颌肌张力障碍(每10万人0.57例;95%置信区间=0.15-2.15)以及特发性或遗传性孤立性肌张力障碍所有亚型合并症(每10万人30.85例;95%置信区间=5.06-187.74)的患病率进行了随机效应荟萃分析。所有研究均报告女性肌张力障碍病例更多。根据研究发表时间(1985-2010年与2010-2022年)进行亚组分析,患病率无显著差异。使用所有已发表研究(1985-2022年)按大陆对肌张力障碍亚型患病率差异进行亚组分析,结果显示颈部和喉肌张力障碍的患病率存在显著的地区差异。
过去十年中特发性或遗传性孤立性肌张力障碍的发病率和患病率与早期报告无显著差异。需要在多个地理区域开展基于人群的研究,以更清楚地了解这种疾病的流行病学情况。